Abstract
The most common indications for gastric operation are morbid obesity, neoplasm, gastrostomy tube placement, and ulcer disease. This chapter discusses important concepts relevant to the choice of operation for these common indications and the management of postoperative complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long term survival. JAMA. 2015;313:62–70.
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. NEJM. 2017;377:1143–55.
Mehaffey JH, LaPar DJ, Clement KC, et al. 10 year outcomes after roux en Y gastric bypass. Ann Surg. 2016;264:121–6.
Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017;265(3):466–73.
Lazzati A, De Antonio M, Paolino L, et al. Natural History of Adjustable Gastric Banding: Lifespan and Revisional Rate: A Nationwide Study on Administrative Data on 53,000 Patients. Ann Surg. 2017;265(3):439–45.
Rowland SP; Dharmarajah B; Moore HM, et al: Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. [Review] Ann Surg. 2015;261(1):35–45.
Bartlett MA; Mauck KF; Daniels PR: Prevention of venous thromboembolism in patients undergoing bariatric surgery. [Review]. Vascul Health Risk Manag. 2015;11:461–77.
El-Sayes IA, Frenken M, Weiner RA. Management of leakage and stenosis after sleeve gastrectomy. Surgery. 2017;162(3):652–61.
Bradley JF 3rd, Ross SW, Christmas AB, et al. Complications of bariatric surgery: the acute care surgeon's experience. Am J Surg. 2015;210(3):456–61.
Bozzetti F, Marubini E, Bonafanti G, et al. Subtotal versus total gastrectomy for gastric cancer: fi ve-year survival rates in a multicenter randomized Italian trial: Italian gastrointestinal tumor study group. Ann Surg. 1999;230:170–8.
Roukos D, Schmidt-Mathiesen A, Encke A, et al. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long term survival analysis with emphasis on Lauren classification. Surg Oncol. 1995;4:323–32.
Robertson CS, Chung SCS, Woods SDS, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994;220:176–82.
Lee SS, Chung HY, Kwon OK, Yu W. Long term quality of life after distal subtotal and total gastrectomy—symptom and behavior oriented consequences. Ann Surg. 2016;263(4):738–44.
Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal only approach: results and comparisons to distal adenocarcinoma of the stomach. Ann Surg. 1997;225:678–85.
Aronow JS, Matthews JB, Garcia-Aguilar J, et al. Isoperistaltic jejunal interposition for intractable postgastrectomy alkaline reflux gastritis. J Am Coll Surg. 1995;180:648.
Gertler R, Rosenberg R, Feith M, et al. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol. 2009;104(11):2838–51.
Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114.
Degiuli M, De Manzoni G, Di Leo A, et al. Gastric cancer—current status of lymph node dissection. World J Gastroenterol. 2016;22:2875–93.
Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet. 1996;347:995.
Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79(9–10):1522.
Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908.
Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069.
Jiang L, Yang KH, Guan QL, et al. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807.
El-Sedfy A, Dixon M, Seevaratnam R, et al. Personalized surgery for gastric adenocarcinoma: a meta-analysis of D1 versus D2 lymphadenectomy. Ann Surg Oncol. 2015;22:1820.
Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439.
Mocellin S, McCulloch P, Kazi H, et al. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2015;
Ajani JA, D’Amico TA, Almhanna K, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J National Compreh Cancer Network. 2016;14(10):1286–312.
Han S, Hsu A, Wassef WY. An update in the endoscopic management of gastric cancer. Curr Opin Gastroenterol. 2016;32(6):492–500.
Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17:3173–80.
Honda M, Hiki N, Kinoshita T, et al. Long-term outcomes of laparoscopic versus open surgery for clinical stage I gastric cancer: the LOC-1 study. Ann Surg. 2016;264:214–22.
Brenkman HJF, Gisbertz SS, Slaman AE, et al. Postoperative outcomes of minimally invasive gastrectomy versus open gastrectomy during the early introduction of minimally invasive gastrectomy in the netherlands: a population-based Cohort Study. Ann Surg. 2017;266(5):831–8.
Kingham TP, DeMatteo RP. Multidisciplinary treatment of gastrointestinal stromal tumors. Surg Clin N Am. 2009;89(1):217–33.
Keung EZ, Raut CP. Management of Gastrointestinal Stromal Tumors. Surg Clin N Am. 2017;97(2):437–52.
Balachandran VP, DeMatteo RP. Gastrointestinal stromal tumors: who should get imatinib and for how long? Adv Surg. 2014;48:165–83.
Ho MY, Blanke CD. Gastrointestinal stromal tumors—disease and treatment update. Gastroenterology. 2011;140:1372–6.
Xiong H, Wang J, Jia Y, et al. Laparoscopic surgery versus open resection in patients with gastrointestinal stromal tumors: An updated systematic review and meta-analysis. Am J Surg. 2017;214(3):538–46.
Calam J, Baron JH. ABC of the upper gastrointestinal tract: pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ. 2001;323(7319):980–2.
Lee CW, Sarosi GA Jr. Emergency ulcer surgery. Surg Clin N Am. 2011;91(5):1001–13.
Vaduganathan M; Bhatt DL; Cryer BL; et al: Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy. J Am Colle Cardiol. 2016;67(14):1661–71.
Yazbek PB, Trindade AB, Chin CM, Dos Santos JL. Challenges to the treatment and new perspectives for the eradication of helicobacter pylori. Digest Dis Sci. 2015;60(10):2901–12.
Soreide K, Thorsen K, Harrison EM, et al. Perforated peptic ulcer. Lancet. 2015;386(10000):1288–98.
Hasselager RB, Lohse N, Duch P, Moller MH. Risk factors for reintervention after surgery for perforated gastroduodenal ulcer. Br J Surg. 2016;103(12):1676–82.
Boey J, Lee NW, Koo J, et al. Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg. 1982;196:338–44.
Ng EK, Lam YH, Sung JJ, et al. Eradication of helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000;231(2):153–8.
Wilhelmsen M, Moller MH, Rosenstock S. Surgical complications after open and laparoscopic surgery for perforated peptic ulcer in a nationwide cohort. Br J Surg. 2015;102(4):382–7.
Jordan PH, Thornby J. Perforated pyloroduodenal ulcers: long-term results with omental patch closure and parietal cell vagotomy. Ann Surg. 1995;221:479–88.
Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251(1):51–8.
Lagoo J, Pappas TN, Perez A. A relic or still relevant: the narrowing role for vagotomy in the treatment of peptic ulcer disease. Am J Surg. 2014;207(1):120–6.
Harbison SP, Dempsey DT. Peptic ulcer disease. Curr Probl Surg. 2005;42(6):346–454.
Vaezi MF, Yang Y-X, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153:35–48.
Cohen F, Valleur P, Serra J, et al. Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vagotomy. Ann Surg. 1993;217:253–9.
Rohss K, Wilder-Smith C, Bokelund-Singh S, et al. Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation. Dig Dis Sci. 2010;55(12):3423–9.
Vogel SB, Drane WE, Woodward ER. Clinical and radionuclide evaluation of bile diversion by Braun enteroenterostomy: prevention and treatment of alkaline reflux gastritis: an alternative to Roux-en-Y diversion. Ann Surg. 1994;219:458–65.
Yusuf TE, Brugge WR. Endoscopic therapy of benign pyloric stenosis and gastric outlet obstruction. Curr Opin Gastroenterol. 2006;22(5):570–3.
Csendes A, Maluenda F, Braghetto I, et al. Prospective randomized study comparing three surgical techniques for the treatment of gastric outlet obstruction secondary to duodenal ulcer. Am J Surg. 1993;166(1):45–9.
Laine L. Clinical practice upper gastrointestinal bleeding due to a peptic ulcer. New Engl J Med. 2016;374(24):2367–76.
Calvet X, Vergara M, Brullet E, et al. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology. 2004;126(2):441–50.
Schroder VT, Pappas TN, Vaslef SN, et al. Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. Ann Surg. 2014;259(6):1111–8.
Emas S, Grupcev G, Eriksson B. Ten-year follow-up of a prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy for treating corporeal gastric ulcer. Am J Surg. 1994;167(6):596–600.
Millat B, Fingerhut A, Borie F. Surgical treatment of complicated duodenal ulcers: controlled trials. World J Surg. 2000;24:299–306.
Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.
Mendelson AH, Donowitz M. Catching the zebra: clinical pearls and pitfalls for the successful diagnosis of Zollinger-Ellison syndrome. Digest Dis Sci. 2017;62(9):2258–65.
Berg P, McCallum R. Dumping syndrome: a review of the current concepts of pathophysiology, diagnosis, and treatment. Digest Dis Sci. 2016;61(1):11–8.
Miedema BW, Kelly KA. The roux operation for postgastrectomy syndromes. Am J Surg. 1991;161:256–61.
Raimes SA, Wheldon EJ, Smirniotis V, Venables CW, Johnston IDA: Postvagotomy diarrhea put into perspective. Lancet. 1986;851–3.
Malchow-Moller A; Frederiksen HJ; Sparso BH, et al: Postvagotomy diarrhea. Lancet. 1986;2(8521–22):1465.
Davis JL, Ripley RT. Postgastrectomy syndromes and nutritional considerations following gastric surgery. Surg Clin N Am. 2017;97(2):277–93.
Ritchie Jr WP. Alkaline reflux gastritis: Late results on a controlled trial of diagnosis and treatment. Ann Surg 203:537–544, 1986.
Malagelada JR, Phillips SF, Shorter RG, et al. Postoperative reflux gastritis: pathophysiology and long-term outcome after Roux-en-Y diversion. Ann Intern Med 1985;103:178.
Schirmer BD. Gastric atony and the roux syndrome. Gastroenterol Clin N Am. 1994;23:327–43.
Forstner-Barthell AW, Murr MM, Nitecki S, et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg. 1999;3(1):15–21; discussion 21–3.
Speicher JE, Thirlby RC, Burggraaf J, Kelly C, Levasseur S. Results of completion gastrectomies in 44 patients with postsurgical gastric atony. J Gastrointest Surg. 2009;13(5):874–80.
Vogel SB, Woodward ER. The surgical treatment of chronic gastric atony following Roux-Y diversion for alkaline reflux gastritis. Ann Surg. 1989;209:756–61.
Navas CM, Patel NK, Lacy BE. Gastroparesis: medical and therapeutic advances. Digest Dis Sci. 2017;62(9):2231–40.
Harju E. Metabolic problems after gastric surgery. Int Surg. 1990;75(1):27–35.
Hu Y, Kim HI, Hyung WJ, et al. Vitamin B(12) deficiency after gastrectomy for gastric cancer: an analysis of clinical patterns and risk factors. Ann Surg. 2013;258(6):970–5.
Ichikawa C, Takiguchi N, Koda K, et al. Early phase metabolic bone disorders after gastrectomy: influence of active vitamin D treatment. Digest Dis Sci. 2002;47(8):1886–90.
Ledoux S, Calabrese D, Bogard C, et al. Long-term evolution of nutritional deficiencies after gastric bypass: an assessment according to compliance to medical care. Ann Surg. 2014;259(6):1104–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harbison, S.P., Dempsey, D.T. (2022). Concepts in Surgery of the Stomach and Duodenum. In: Scott-Conner, C.E.H., Kaiser, A.M., Nguyen, N.T., Sarpel, U., Sugg, S.L. (eds) Chassin's Operative Strategy in General Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-81415-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-81415-1_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81414-4
Online ISBN: 978-3-030-81415-1
eBook Packages: MedicineMedicine (R0)